TipRanks
Go Ultimate55% OFF

Brii Biosciences Limited (2137) Ownership - Who Owns Brii Biosciences Limited?

3 Followers

Brii Biosciences Limited (2137) Ownership Overview

  • 0.05% Mutual Funds
  • 0.05% ETFs
  • 99.90% Public Companies and Individual Investors

The ownership structure of Brii Biosciences Limited (HK:2137) stock is a mix of institutional, retail, and individual investors. Approximately 0.10% of the company’s stock is owned by Institutional Investors, and 99.90% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue

Top Shareholders

HK:2137 top shareholders
Holder# of SharesType% HoldingValue
Dfa Investment Dimensions Group Inc373,000Institution0.05%48,490
Avantis366,500Institution0.05%47,645

Top Mutual Fund Holders

HK:2137 top mutual fund holders
Holder# of SharesType% HoldingValue
Dfa Investment Dimensions Group Inc373,000Institution0.05%48,490

Top ETF Holders

HK:2137 top ETF holders
Holder# of SharesType% HoldingValue
Avantis, AVEM ETF338,000Institution0.05%42,108
Avantis, AVSE ETF28,500Institution<0.01%3,551

FAQ

What percentage of Brii Biosciences Limited (HK:2137) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.10% of Brii Biosciences Limited (HK:2137) stock is held by institutional investors: 0.05% by mutual funds and 0.05% by ETFs.
What percentage of Brii Biosciences Limited (HK:2137) stock is held by retail investors?
According to the latest TipRanks data, approximately 99.90% of Brii Biosciences Limited (HK:2137) stock is held by public companies and individual investors.
Who owns the most shares of Brii Biosciences Limited (HK:2137)?
DFA INVESTMENT DIMENSIONS GROUP INC owns the most shares of Brii Biosciences Limited (HK:2137).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.